These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 9116774

  • 1. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM, Loumaye E, Alvarez S, Merviel P, Cornet D, Mandelbaum J, Salat-Baroux J.
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [Abstract] [Full Text] [Related]

  • 2. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 3. [Hyperstimulation for in vitro fertilization with the "step-down" technique. Preliminary results from a prospective randomized study with and without LHRH agonists].
    Antoine JM, Salat-Baroux J, Alvarez S, Cornet D, Firmin C, Mandelbaum J, Plachot M.
    Contracept Fertil Sex; 1993 May; 21(5):408-11. PubMed ID: 7920930
    [Abstract] [Full Text] [Related]

  • 4. Recombinant gonadotropins.
    Lathi RB, Milki AA.
    Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
    [Abstract] [Full Text] [Related]

  • 5. [Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer].
    Xu SR, Li Y, Liu H, Li HY, Tang R, Gao Q, Sheng Y, Chen ZJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):420-3. PubMed ID: 21029591
    [Abstract] [Full Text] [Related]

  • 6. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH, Agdi M, Shehata F, Son W, Tan SL.
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [Abstract] [Full Text] [Related]

  • 7. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T.
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [Abstract] [Full Text] [Related]

  • 8. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
    Loutradis D, Elsheikh A, Kallianidis K, Drakakis P, Stefanidis K, Milingos S, Michalas S.
    Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
    [Abstract] [Full Text] [Related]

  • 9. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
    Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC.
    Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
    [Abstract] [Full Text] [Related]

  • 10. [Use of purified FSH in female infertility].
    Antoine JM, Salat-Baroux J.
    Contracept Fertil Sex; 1993 Apr; 21(4):301-6. PubMed ID: 7951630
    [Abstract] [Full Text] [Related]

  • 11. The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation.
    Yazıcı Yılmaz F, Görkemli H, Çolakoğlu MC, Aktan M, Gezginç K.
    Gynecol Endocrinol; 2015 Feb; 31(2):141-4. PubMed ID: 25237892
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic induction of ovulation: towards the replacement of hCG with LH].
    Emperaire JC.
    Contracept Fertil Sex; 1994 Feb; 22(7-8):459-67. PubMed ID: 7920947
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY, Choi YS, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH.
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
    Baker VL, Fujimoto VY, Kettel LM, Adamson GD, Hoehler F, Jones CE, Soules MR.
    Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
    [Abstract] [Full Text] [Related]

  • 20. Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program.
    Bianchi V, Dal Prato L, Maccolini A, Mazzone S, Borini A.
    Fertil Steril; 2009 Nov; 92(5):1747.e1-3. PubMed ID: 19732874
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.